Chauvet Véronique, Qian Feng, Boute Nicolas, Cai Yiqiang, Phakdeekitacharoen Bunyong, Onuchic Luis F, Attié-Bitach Tania, Guicharnaud Liliane, Devuyst Olivier, Germino Gregory G, Gubler Marie-Claire
INSERM U423 and the Département deGénétique et Unité INSERM U393, Hôpital Necker-Enfants Malades, Paris, France.
Am J Pathol. 2002 Mar;160(3):973-83. doi: 10.1016/S0002-9440(10)64919-X.
Autosomal-dominant polycystic kidney disease, one of the most frequent human genetic disorders, is genetically heterogeneous. Most cases result from mutations of PKD1 or PKD2 encoding polycystin-1 or polycystin-2, respectively. Polycystin-1 is a large transmembrane protein containing several domains involved in cell-cell and/or cell-matrix interactions. Polycystin-2 is transmembrane glycoprotein sharing homology with some families of cation channels. Despite a large number of reports, the tissue distribution of these two proteins, especially of polycystin-1, is still debated. We investigated the expression pattern of PKD1 and PKD2 transcripts and proteins during human embryogenesis and kidney development, using Northern blot analysis, in situ hybridization, and immunohistochemical methods. For each gene, the expression pattern of transcripts and protein was concordant. In human 5- to 6-week-old embryos, both genes are widely expressed, mainly in neural tissue, cardiomyocytes, endodermal derivatives, and mesonephros. At this age, PKD2 but not PKD1 expression is observed in the ureteric bud and the uninduced metanephros. Thereafter, PKD2 is diffusely expressed at all stages of nephron development, whereas high PKD1 expression first appears in differentiated proximal tubules. Proximal tubule expression of both genes decreases from weeks 20 to 24 onwards. PKD1 transcripts, later restricted to distal tubules in fetal nephrogenesis, are no longer detected in adult kidneys, which nevertheless maintain a faint expression of polycystin-1, whereas persistent expression of PKD2 transcripts and protein is observed throughout nephrogenesis. Overall, contrary to previous observations, we found profound differences in the spatiotemporal expression of PKD1 and PKD2 during nephrogenesis, PKD2 being expressed earlier and more diffusely than PKD1. These data suggest that polycystins could interact with different partners, at least during kidney development.
常染色体显性多囊肾病是人类最常见的遗传性疾病之一,具有遗传异质性。大多数病例分别由编码多囊蛋白-1或多囊蛋白-2的PKD1或PKD2基因突变引起。多囊蛋白-1是一种大型跨膜蛋白,包含几个参与细胞间和/或细胞与基质相互作用的结构域。多囊蛋白-2是一种跨膜糖蛋白,与一些阳离子通道家族具有同源性。尽管有大量报道,但这两种蛋白的组织分布,尤其是多囊蛋白-1的组织分布仍存在争议。我们使用Northern印迹分析、原位杂交和免疫组化方法,研究了PKD1和PKD2转录本及蛋白在人类胚胎发生和肾脏发育过程中的表达模式。对于每个基因,转录本和蛋白的表达模式是一致的。在人类5至6周龄的胚胎中,这两个基因均广泛表达,主要在神经组织、心肌细胞、内胚层衍生物和中肾中表达。在这个年龄段,在输尿管芽和未诱导的后肾中观察到PKD2的表达,但未观察到PKD1的表达。此后,PKD2在肾单位发育的所有阶段均呈弥漫性表达,而PKD1的高表达首先出现在分化的近端小管中。从第20周到第24周起,这两个基因在近端小管中的表达均下降。PKD1转录本在胎儿肾发生过程中后来局限于远端小管,在成年肾脏中不再检测到,尽管如此,成年肾脏仍维持着多囊蛋白-1的微弱表达,而在整个肾发生过程中均观察到PKD2转录本和蛋白的持续表达。总体而言,与先前的观察结果相反,我们发现在肾发生过程中PKD1和PKD2的时空表达存在深刻差异,PKD2的表达比PKD1更早且更广泛。这些数据表明,多囊蛋白至少在肾脏发育过程中可能与不同的伙伴相互作用。